V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20199648 | 20158122 | 1.65 | 41.8 | 03 | 2019-07-17 | 2019-07-22 | EEF or EOF | 02 | N | ETOPOSIDE + IFOSFAMIDE | 100122884 |
| 20199729 | 20158123 | 1.88 | 82.2 | null | 2020-05-02 | 2020-05-31 | DA 3+8 | 02 | null | COSMIC TRIAL | 100995507 |
| 20200205 | 20158124 | 1.51 | 46.8 | Neo-adjuvant (N) | null | 2018-07-05 | Binimetinib + Encorafenib | 2 | N | DARATUMUMAB | 100355560 |
| 20200367 | 20158125 | 1.73 | 80.9 | Adjuvant (A) | 2016-07-15 | 2016-08-16 | SOTORASIB | 02 | N | EPIRUBICIN + FLUOROURACIL + OXALIPLATIN | 101569823 |
| 20200379 | 20158126 | 1.58 | 105.8 | Palliative (P) | 2021-05-30 | 2021-10-21 | Cisplatin +FU +Trastuzumab - Maint | 02 | N | CAPECITABINE + CISPLATIN + STREPTOZOCIN | 101544874 |
| 20200823 | 20158127 | 1.64 | 56.2 | Palliative (P) | 2018-09-02 | 2018-09-27 | null | 02 | N | ACTICCA-1 TRIAL | 100337471 |
| 20201166 | 20158128 | 1.79 | 80.2 | null | 2018-05-09 | 2018-08-10 | Pemigatinib | 02 | N | EVEROLIMUS + LENVATINIB | 100687744 |
| 20201314 | 20158129 | 1.75 | 94.6 | Neo-adjuvant (N) | 2017-12-01 | 2018-10-11 | EEF or EOF | 02 | N | BACILLUS CALMETTE-GUERIN | 101256435 |
| 20201351 | 20158130 | 1.78 | 62 | Curative (C) | 2020-04-10 | 2020-04-11 | CISPLATIN + FLUOROURACIL + Trastuzumab | 02 | N | CARBOPLATIN + PEMETREXED | 100065020 |
| 20201451 | 20158131 | 1.86 | 73 | null | 2021-11-15 | 2021-11-15 | Nintedanib | 01 | null | CYCLOPHOSPHAMIDE + DOCETAXEL + EPIRUBICIN + FLUOROURACIL | 101639167 |
| 20201545 | 20158132 | 1.81 | 65 | Palliative (P) | 2020-11-10 | 2020-11-19 | Doxorubicin 75mg/m2 | 02 | Y | PHITT F PLADO/SORAFENIB | 100831795 |
| 20201595 | 20158133 | 1.57 | 83.1 | 03 | 2020-10-27 | 2020-10-30 | SCOPE 2 TRIAL | 02 | N | ECARBOX | 100669388 |
| 20201779 | 20158134 | 1.8 | 95.5 | Palliative (P) | 2018-08-10 | 2018-08-10 | EEF or EOF | 02 | N | COSMIC TRIAL | 100372276 |
| 20201824 | 20158135 | 1.84 | 50.4 | Palliative (P) | 2018-01-14 | 2018-09-19 | EOF | 02 | N | BORTEZOMIB + THALIDOMIDE | 100763172 |
| 20202307 | 20158137 | 1.77 | 105.6 | null | 2015-02-04 | 2017-04-18 | CEMIPLIMAB | N | null | ECF | 100270258 |
| 20202543 | 20158139 | 1.51 | 61.2 | Palliative (P) | 2018-01-20 | 2018-02-03 | PACLITAXEL + RAMUCIRUMAB | 02 | N | PEMETREXED | 100765754 |
| 20202716 | 20158140 | 1.57 | 52.3 | null | 2021-02-14 | 2021-02-25 | CHOP R - 21 days | 2 | N | ECF | 100129577 |
| 20203047 | 20158142 | 1.72 | 21.2 | Palliative (P) | 2019-08-30 | 2019-10-24 | CAPE + OXALIPLATIN + TRASTUZUMAB | 02 | N | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 101847148 |
| 20203072 | 20158143 | 1.79 | 62.1 | Palliative (P) | 2021-08-05 | 2021-08-19 | Cape+Cetuximab+Oxalip (2 wk) Maint | 02 | N | CAPECITABINE + STREPTOZOCIN | 100822352 |
| 20203204 | 20158144 | 1.71 | 79 | null | 2020-09-26 | 2020-09-26 | Topotecan (oral) | 02 | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + VINCRISTINE | 101602500 |
| 20203355 | 20158145 | 1.75 | 66.2 | null | 2017-12-04 | 2017-12-29 | PHITT Trial | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + VINCRISTINE | 101802754 |
| 20203480 | 20158146 | 1.89 | 55.1 | Neo-adjuvant (N) | null | 2020-03-29 | Fulvestrant + Palbociclib | 99 | N | MIDOSTAURIN | 101053316 |
| 20203627 | 20158147 | 1.58 | 72 | null | 2021-10-08 | 2021-10-08 | Venetoclax | 02 | null | TCX | 101042890 |
| 20203679 | 20158148 | 1.82 | 68.3 | null | 2019-11-18 | 2019-12-19 | Cisplatin + Radiotherapy | 02 | null | IRINOTECAN + MDG + PANITUMUMAB | 101039595 |
| 20203794 | 20158149 | 1.57 | 83.8 | 03 | 2017-09-25 | 2018-08-29 | ETOPOSIDE | 02 | null | GEMCITABINE + OXALIPLATIN | 100679328 |
| 20203839 | 20158150 | 1.87 | 105.3 | Palliative (P) | null | 2020-01-05 | ECF | null | N | IRINOTECAN + RALTITREXED | 101501743 |
| 20203844 | 20158151 | 1.69 | 115.9 | Palliative (P) | 2020-12-18 | 2020-12-18 | Bortezomib + MELPHALAN | N | Y | CARBOPLATIN + CYCLOPHOSPHAMIDE + DOXORUBICIN + PACLITAXEL | 100156914 |
| 20203961 | 20158152 | 1.81 | 56 | null | 2019-11-28 | 2019-12-07 | POMALIDOMIDE | 02 | null | BORTEZOMIB + DARATUMUMAB | 100699246 |
| 20204002 | 20158153 | 1.65 | 56.8 | null | 2019-11-21 | 2019-12-26 | CAV | null | N | CISPLATIN + FLUOROURACIL + RT | 101176113 |
| 20204109 | 20158155 | 1.65 | 101.8 | Curative (C) | 2019-05-25 | 2019-05-25 | FCarboSt | 02 | N | CAPE + OXALIPLATIN + TRASTUZUMAB | 100726984 |
| 20204380 | 20158156 | 1.71 | 44.1 | Neo-adjuvant (N) | 2017-12-04 | 2019-09-15 | Carboplatin + Vinorelbine Oral | null | null | INTERAACT TRIAL | 100099922 |
| 20204408 | 20158157 | 1.8 | 62.8 | 03 | 2017-08-01 | 2018-02-04 | PACLITAXEL + RAMUCIRUMAB | null | N | IPILIMUMAB | 101403143 |
| 20204423 | 20158158 | 1.65 | 83.3 | Palliative (P) | 2021-04-06 | 2021-04-06 | FOXTROT TRIAL | N | null | CISPLATIN + RALTITREXED + TRASTUZUMAB | 100383333 |
| 20204466 | 20158160 | 1.61 | 89.5 | Curative (C) | 2018-08-24 | 2018-08-31 | Gemcitabine + Oxaliplatin | 01 | null | CABAZITAXEL | 101045666 |
| 20204510 | 20158161 | 1.72 | 86.6 | Palliative (P) | 2020-06-15 | 2020-08-01 | SCOPE 2 TRIAL | N | null | COSMIC TRIAL | 101478155 |
| 20204742 | 20158162 | 1.8 | 63 | null | 2018-05-05 | 2018-05-20 | null | 02 | Y | ECARBOX | 100327205 |
| 20204955 | 20158163 | 1.75 | 57.5 | Adjuvant (A) | 2021-04-09 | 2021-04-10 | Cladribine IV weekly | 02 | null | BEVACIZUMAB + FLUOROURACIL + IRINOTECAN | 100856300 |
| 20205115 | 20158164 | 1.8 | 75 | null | 2018-06-18 | 2018-07-09 | Rucaparib | 02 | null | CARBOPLATIN + DOCETAXEL + TRASTUZUMAB | 101497520 |
| 20205252 | 20158165 | 1.54 | 63 | Curative (C) | 2021-04-04 | 2021-04-09 | Lomustine | N | null | PEMETREXED | 101853630 |
| 20205393 | 20158166 | 1.6 | 58.2 | Curative (C) | 2019-10-21 | 2019-11-11 | Bevacizumab + Irinotecan + MdG | 02 | N | AFATINIB | 100502456 |
| 20205425 | 20158167 | 1.77 | 65.6 | Palliative (P) | 2016-09-01 | 2016-09-01 | Etoposide + Ifosfamide (5 days) | N | N | CAV | 101035569 |
| 20205674 | 20158168 | 1.55 | 79.7 | Curative (C) | 2018-10-27 | 2018-11-29 | IBRUTINIB | 02 | N | DOXORUBICIN | 101791858 |
| 20205748 | 20158169 | 1.77 | 96 | null | 2016-09-23 | 2017-11-18 | EEF or EOF | 02 | null | PHITT C SIOPEL-3HR | 100908183 |
| 20205829 | 20158171 | 1.97 | 88.4 | null | 2019-01-11 | 2019-01-11 | CARBOPLATIN + GEMCITABINE | 02 | N | AFLIBERCEPT + IRINOTECAN + OXALIPLATIN + MDG | 101085882 |
| 20206048 | 20158173 | 1.81 | 77.6 | Palliative (P) | 2019-10-19 | 2019-10-19 | AFATINIB | 02 | N | BEVACIZUMAB + CAPECITABINE + OXALIPLATIN | 101257517 |
| 20206119 | 20158174 | 1.75 | 78 | null | 2017-12-02 | 2018-01-06 | Carboplatin + Fluorouracil + Streptozocin | 02 | null | IRINOTECAN + RALTITREXED | 100637538 |
| 20206443 | 20158175 | 1.81 | 80.7 | Curative (C) | 2018-11-15 | 2018-12-05 | ECF | 02 | N | PEMETREXED | 101450822 |
| 20206480 | 20158176 | 1.69 | 77.1 | null | 2018-04-03 | 2018-04-03 | Hydroxycarbamide | N | null | TRABECTEDIN | 100364677 |
| 20206498 | 20158177 | 1.75 | 78.9 | null | 2018-02-12 | 2018-09-14 | OXALIPLATIN + MDG + PANITUMUMAB | 02 | null | LETROZOLE + RIBOCICLIB | 101349727 |
| 20206530 | 20158178 | 1.71 | 94.5 | null | 2019-02-15 | 2019-03-21 | ISATUXIMAB + POMALIDOMIDE | 02 | null | CARBOPLATIN + VINORELBINE | 101395576 |